Just now, Matt Herper, writing at Forbes picked up on my meme, in this morning's live-blog session, about whether CEO Hassan's February 2009 "generally stabilizing" comments were truthful when made, thus (do go read it all):
. . . .Plummeting U.S. Zetia sales were partly counteracted by global growth. But Vytorin sales fell 37% in the U.S. and 7% outside the U.S.; executives at Merck and Schering had previously said international growth would help stabilize the franchise. . . .
[Ed. Note: Emphasis supplied.]
Um, cue the plaintiffs' securities lawyers. I'll report when (not if) the first federal suit files.
No comments:
Post a Comment